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Abstract
Background. Infections caused by multidrug-resistant organisms (MDRO) are difficult to treat and associated with 
poor outcomes for patients. Therefore, early identification and management of colonization are essential as first steps 
in infection prevention. Culture-based methods have been widely used for MDRO screening. The turnaround time 
(TAT) for the identification of carriers varies between 48-72 h with this method. The aim of our study was to compare 
the performance of the new rapid semiautomatic method for detection of MDRO (HB&L Uroquattro, Alifax) with 
standard cultivation on selective media.
Methods. Twenty-one axillary, 20 nose and 19 rectal swabs were taken in duplicate on two selected days at the 
University Hospital Centre Split, Croatia. Swabs were cultivated and MDRO isolates were identified on selective media 
(Chromagar MRSA and Chromagar ESBL) according to the standard operating procedure. Novel Alifax method was 
performed according to manufacturer’s instructions.
Results. TAT for the new method was significantly lower (6.5 h) in comparison to the classical method. With classical 
method, 10 extended spectrum ß-lactamases (ESBL) producing strains from 10 different rectal specimens were isola-
ted on Chromagar ESBL media. Exactly the same specimens were positive for the presence of ESBL-producing bacteria 
by rapid Alifax method. On selective Chromagar MRSA media, 11 MDRO were isolated, while rapid method detected 
11 MDRO from the same specimens.
Conclusions. High concordance of positive and negative results obtained with classical and rapid method is enco-
uraging. However, our study was performed on a small sample size and further research with larger sample size is 
needed.
Sažetak
Uvod: Infekcije uzrokovane višestruko otpornim organizmima (MDRO) se teško liječe i često imaju nepovoljan 
ishod za bolesnika. Budući da infekciji najčešće prethodi kolonizacija, rana identifikacija koloniziranih bolesnika 
je neophodna u prevenciji nastanka infekcije. Za probir MDRO najčešće se koriste kultivacijske metode kojima 
vrijeme potrebno za izdavanje nalaza (TAT) iznosi od 48 do 72 h.
Cilj ove studije bio je usporediti rezultate nove, brze, poluautomatske metode za detekciju MDRO (HB&L Uroquat-
tro, Alifax) sa standardnom kultivacijom na selektivnim podlogama.
Metode/materijali: Tijekom dva nasumično odabrana dana, bolesnicima hospitaliziranima u Kliničkom 
bolničkom centru Split, uzorkovano je ukupno 21 aksilarnih, 19 rektalnih te 20 briseva vestibuluma nosa. Sva-
ki obrisak je prikupljen u duplikatu, jedan za kultivacijsku, a drugi za brzu poluatomatsku metodu. Brisevi su 
kultivirani i MDRO izolati identificirani na selektivnim podlogama (Chromagar MRSA i Chromagar ESBL) prema 
standardnom laboratorijskom protokolu. Nova Alifaxova metoda je provedena prema uputama proizvođača.
Rezultati: U usporedbi s klasičnom metodom, TAT nove metode je bio značajno kraći (6,5 h). Klasičnom 
metodom je na Chromagar ESBL selektivnom mediju izolirano 10 sojeva koji stvaraju ß-laktamaze proširenog 
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and efflux overproduction. However, the production 
of extended-spectrum β-lactamases (ESBL), broad 
spectrum β-lactamases which are able to hydrolyse 
expanded-spectrum β-lactam antibiotics, is the most 
significant mechanism and was first described in 1985 
in a Klebsiella pneumoniae strain[8]. By the end of the 
decade, a broad range of bacteria producing these 
enzymes have been identified in healthcare facilities 
worldwide. Today, ESBL is one of the most common 
resistance mechanisms of Gram-negative bacteria and 
ESBL-producing bacteria represent one of the most 
important groups of nosocomial pathogens[9,10]. More-
over, high colonization rates among hospitalized and 
non-hospitalized individuals have been detected[11,12]. 
One suggested risk factor for the development of ESBL 
infection is gut colonization with these organisms. 
Karanika and colleagues in their meta-analysis of 66 
studies report a global prevalence of ESBL faecal col-
onization of 14%. A recent cohort study performed 
by Cornejo-Juarez and colleagues in patients with 
hematologic malignancies revealed that patients with 
faecal ESBL colonization were 3.5 times more likely to 
develop ESBL bacteraemia compared with those not 
colonized[13,14].
 High prevalence of MDRO among patients in in-
tensive care units (ICU) raises particular concerns 
that require improved prevention and control strate-
gies. Vertical approaches are mainly based on screen-
ing and contact precautions and/or decolonization of 
MDRO carriers. On the other hand, horizontal strate-
gies include standard precautions (i.e., hand hygiene), 
universal decolonization, antimicrobial stewardship, 
and environmental cleaning[15].
 One goal of this strategy is to identify patients who 
are colonized with a MDRO as early as possible. This 
aligns with recommendations to screen those with a 
high risk of being colonized with an MDRO, like ICU 
patients[16]. Admission screening is an effective com-
ponent of infection control interventions to control 
ESBL outbreaks and is recommended in several guide-
lines for the control of drug resistant Gram-positive 
organisms such MRSA[17]. Screening for MRSA colo-
nization at admission using culture-based approaches 
requires 24 to 72 hours until the results are available 
on the wards. During this time MRSA can spread 
among inpatients. Köck and colleagues concluded that 
Introduction
 High rate of antimicrobial resistance (AMR) to 
multiple agents has been observed among Gram-neg-
ative and Gram-positive bacteria worldwide and rep-
resents a serious healthcare concern on the local and 
national level. Multidrug resistance (MDR) is defined 
as acquired non-susceptibility to at least one agent 
in three or more antimicrobial categories. Infections 
caused by these highly resistant bacteria are associated 
with higher morbidity and mortality rates, can lead to 
inadequate or delayed antimicrobial therapy and are 
associated with poorer patient outcomes[1].
 The European Centre for Disease Prevention and 
Control (ECDC) has estimated that infections caused 
by multidrug resistant organisms (MDRO) are respon-
sible for about 25 000 deaths in Europe annually[2].
 Among clinically significant MDRO are methi-
cillin-resistant Staphylococcus aureus (MRSA) and 
extended-spectrum β-lactamase (ESBL) producing 
Gram-negative bacilli such as Escherichia coli and 
Klebsiella pneumoniae[3].
 Methicillin resistance in S. aureus is the result of 
a decreased binding affinity of methicillin to its tar-
get, penicillin binding protein 2 (PBP2), owing to ac-
quisition of an altered PBP2 (PBP2a) encoded by the 
mecA gene harboured on a mobile genetic element, the 
staphylococcal chromosome cassette mec (SCCmec). 
Even though MRSA has showed a decreasing trend 
during the last decade, it is still important nosocomial 
pathogen and a matter of greatest importance for pub-
lic health[4,5]. S. aureus, including MRSA, is a common 
colonizer of the nares. The absence of MRSA nares col-
onization has reported to be the negative predictor of 
MRSA pulmonary infections, specifically pneumonia. 
Nasal surveillance of MRSA colonization is used for 
infection control and prevention purposes. However, 
recent literature has highlighted MRSA nasal screen-
ing as a useful antimicrobial stewardship screening 
test for avoiding unnecessary empiric MRSA therapy, 
including vancomycin[6].
 Multidrug-resistant Gram-negative bacilli are 
emerging as a major challenge to human health, es-
pecially in low- and middle-income countries[7]. Re-
sistance to broad-spectrum antibiotics is commonly 
observed in Enterobacterales family and may occur by 
different mechanisms, including permeability defects 
spektra (ESBL) iz 10 različitih rektalnih uzoraka. Isti uzorci su bili pozitivni na prisustvo ESBL- producirajućih bak-
terija brzom Alifaxovom metodom. Kultivacijom na selektivnom Chromagar MRSA mediju i brzom metodom 
otkriveno je 11 uzoraka pozitivnih na prisustvo MDRO.
Zaključak: Visoki stupanj podudarnosti otkrivanja pozitivnih i negativnih uzoraka dobiven klasičnom i novom 
metodom, kao i značajno skraćivanje TAT-a novom metodom je ohrabrujući. Budući je studija provedena na rela-
tivno malom uzorku, potrebno je istraživanje proširiti na veći broj ispitanika.
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and antibiotic susceptibility by using VITEK 2 sys-
tem (bioMérieux, Marcy l´Etoile, France). GP, GN, 
AST–N233, and AST-XN05 VITEK cards were used. 
Methicillin resistance was confirmed by inducing ce-
foxitin (Mastdiscs AST, Merseyside, UK) disk (30 μg), 
while ESBL-production was confirmed by double-disc 
synergy testing (Mastdiscs Combi ESBL ceftazidime 
paired ID discs and Mastdiscs Combi ESBL cefotaxime 
paired ID discs, Merseyside, UK) on Mueller–Hinton 
agar (Liofilchem, Roseto d. Abruzzi, Italy). Plates were 
incubated at 35°C for 24h. The European Committee 
on Antimicrobial Susceptibility Testing (EUCAST) in-
terpretation criteria were applied on all antimicrobial 
testing[19].
 Rapid screening method, based on laser light 
scattering technology, was performed by Uroquattro 
HB&LTM system (Alifax, Padova, Italy). For that pur-
pose, HB&L MRSA (SI 1001.900) and HB&L ESBL/
AmpC (SI 1001.930) kits were used. The screening 
was performed according to the manufacturer’s in-
structions. Briefly, Alifax culture vials were inoculated 
by dipping the swabs into the culture broth for 10-15 
minutes. After that, swabs were removed. Then, regen-
erated supplement (from MRSA or ESBL/AmpC kit) 
was added to the inoculated Alifax vials. The vials were 
placed in the Uroquattro HB&LTM system and incubat-
ed for 6.5 h at 36 °C. The growth phases of bacteria 
were monitored, providing real time growth curves. 
The samples positive to HB&LTM MRSA kit detect the 
presence of Gram-positive bacteria with resistance to 
methicillin/oxacillin/cefoxitin. The positive samples 
to HB&LTM ESBL/AmpC kit detect the presence of 
Gram-negative bacteria with resistance to cephalo-
sporin.
 Results obtained with HB&LTM MRSA and ESBL/
AmpC kits were compared to classical routine method.
Results
 In total, 40 specimens were screened for MRSA col-
onization while 20 specimens were screened for ESBL 
colonization. Of the total of 40 specimens screened 
for MRSA, 2 (5.00 %) were positive. On Chromagar 
MRSA media, besides 2 MRSA strains, another 9 re-
sistant strains were isolated. They were identified as 
coagulase negative methicillin resistant Staphylococcus 
sp. (4 strains) and MDR Acinetobacter baumannii (5 
strains). At the end of incubation time of Alifax vials, 
10 positive samples were detected. They completely 
matched the positive results of classical method, and 
the strains identification was identical.
 Of the total of 20 specimens screened for ESBL, 10 
(50.00%) were positive. With conventional method, 10 
positive ESBL stains from 10 different rectal specimens 
screening can help decrease MRSA infection rates in 
hospitals. The provided evidence support the intro-
duction of MRSA active surveillance programme in 
hyperendemic MRSA settings due to cross-infections 
in spite of the high level of compliance with standard 
precautions[12]. For the detection of ESBL, phenotyp-
ic and genotypic methods are employed. Phenotyp-
ic approaches are based on the detection of synergy 
between β-lactam agents and specific substances that 
inhibit each enzyme type. Genotypic methods, which 
include polymerase chain reaction (PCR) and next 
generation sequencing (NGS) allow for a highly ac-
curate characterization of resistance mechanisms but 
are available only in well-equipped facilities with high 
laboratory budget[18].
 The aim of our study was to evaluate the ability of 
the new rapid, semiautomated liquid-culture method 
to detect ESBL-producing Enterobacterales and MRSA 
in clinical swabs from potentially colonized subjects, 
and to compare it to classical method.
Materials and methods
 On two selected days (September 2017), screen-
ing of MRSA and ESBL-producing Enterobacterales 
colonization was performed on intensive care unit pa-
tients at the University Hospital Centre Split, Croatia. 
In total, 60 clinical specimens (21 axillary’s swabs, 20 
swabs and 19 rectal swabs) were collected. Specimens 
were obtained (with Copan swabs, Brescia, Italy) in 
duplicate, one for rapid and the other one for classical 
MDRO colonization screening.
 Classical method was performed by cultivation on 
solid and liquid selective media. Chromagar MRSA 
(Chromagar, Paris, France), chromogenic medium for 
the isolation and identification of methicillin resistant 
Staphylococcus aureus and Chromagar ESBL (Chro-
magar, Paris, France), chromogenic medium for over-
night detection of Gram-negative bacteria producing 
extended spectrum β-lactamase, were used. These me-
dia contain a mixture of antibiotics and chromogenic 
substrates that helps rapid identification of ESBL-pro-
ducing Enterobacterales and MRSA species, based on 
the specific colour appearance. Nose and axillary’s 
swabs were inoculated on MRSA Chromagar, while 
rectal swabs were inoculated on ESBL Chromagar. In-
oculated plates were incubated aerobically at 35 °C for 
48 h. Also, thioglycollate broth (Liofilchem, Roseto d. 
Abruzzi, Italy) was used for the overnight enrichment. 
On the second day, all liquid media were subcultivated 
on Chromagar MRSA and Chromagar ESBL selective 
media and incubated for another 24h. Presumptive 
colonies of Enterobacterales and MRSA, from prima-
ry subcultivation plates, were tested for identification 
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used kits). Some glucose non-fermenter Gram-nega-
tive bacteria (e.g. Acinetobacter baumannii and Pseu-
domonas aeruginosa) can be resistant to cephalosporin 
used in Alifax kit and therefore give positive results 
despite not being ESBL/AmpC-producing Enterobac-
teriales spp. Similarly, some Gram-positive bacteria 
(e.g. Staphylococcus epidermidis, Staphylococcus hom-
inis, Staphylococcus haemolyticus) can be resistant to 
cefoxitin despite not being MRSA strain.
Conclusions
 High concordance of results obtained with classical 
and rapid screening method is encouraging. Accord-
ing to our findings, novel method is fast and reliable 
and it can be recommended for a routine MDRO 
screening. Isolation precaution measures for colonized 
patients can be implemented on the same day. Addi-
tionally, pre-emptive isolation precaution measures 
after patient transfer from other hospital, long-term 
care facility or high risk ward, can be terminated ear-
lier. However, these results should be confirmed on a 
bigger sample size.
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